Spectral AI, Inc. (NASDAQ: MDAI) announced De Novo clearance for its DeepView Burn diagnostic in a May 26th press release. As a result, we increase our probability of success for DeepView…
Double Bubbler: $10k to $1m Challenge Share Trades and More Exciting Activity!
Even though I focus on a relatively small number of carefully chosen companies, in addition to a generally static portfolio of index trackers and income stocks, even this long weekend…
Spectral AI (MDAI): DeepView AI Automated Wound Imaging System Granted FDA Approval!!!
Well this is the news I and many others have been waiting almost a year for, and certainly in my case expecting given the information in the public domain… the…
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView System
’DALLAS, March 18, 2026 — Spectral AI, Inc. MDAI (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in…
Spectral AI: Zacks maintains $5 valuation and expects mid-2026 FDA decision
https://scr.zacks.com/news/news-details/2026/MDAI-In-the-Blocks-Ready-to-Go-upon-Mid-Year-Authorization-article/default.aspx The principle new information here for me is greater clarity on average FDA timescales for a decision on Spectral AI’s DeepView system. Notably ‘Based on historical data, a De…
Spectral AI: First of Its Kind Automated Wound Healing Prediction
Spectral AI: First of Its Kind Automated Wound Healing Prediction Overview Spectral AI is an artificial intelligence business offering predictive wound diagnostics designed to facilitate faster and more accurate treatment…